Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

UNION MEDICO ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   14.4% 16.3% 13.9% 15.1% 12.2% 4.9% 16.4% 16.4%   Credit score (0-100)   16 12 16 12 18 43 11 11   Credit rating   BB BB BB BB BB BBB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -1,555 -1,566 -1,046 248 1,512 2,949 0.0 0.0   EBITDA   -2,313 -1,954 -1,523 -677 462 1,593 0.0 0.0   EBIT   -2,360 -2,004 -1,560 -697 416 1,547 0.0 0.0   Pre-tax profit (PTP)   -2,850.2 -2,576.8 -2,171.3 -1,313.4 -219.0 922.2 0.0 0.0   Net earnings   -2,380.9 -2,415.2 -71.9 -1,429.0 -84.0 1,731.1 0.0 0.0   Pre-tax profit without non-rec. items   -2,850 -2,577 -2,171 -1,313 -219 922 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   80.5 48.9 11.4 74.0 154 108 0.0 0.0   Shareholders equity total   -19,595 -22,010 -22,082 -23,511 -23,595 -21,864 -22,002 -22,002   Interest-bearing liabilities   21,795 24,134 23,945 24,665 25,397 25,199 22,002 22,002   Balance sheet total (assets)   2,907 4,300 3,584 2,411 4,570 3,551 0.0 0.0   Net Debt   20,401 20,957 21,472 22,889 21,549 23,316 22,002 22,002     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -1,555 -1,566 -1,046 248 1,512 2,949 0.0 0.0   Gross profit growth   14.2% -0.7% 33.2% 0.0% 510.2% 95.0% -100.0% 0.0%   Employees   2 1 1 2 2 3 0 0   Employee growth %   -33.3% -50.0% 0.0% 100.0% 0.0% 50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,907 4,300 3,584 2,411 4,570 3,551 0 0   Balance sheet change%   146.6% 47.9% -16.7% -32.7% 89.6% -22.3% -100.0% 0.0%   Added value   -2,312.7 -1,953.6 -1,522.6 -676.8 436.7 1,592.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -94 -82 -75 42 34 -91 -108 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 -5.0 -5.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   151.8% 128.0% 149.2% -281.3% 27.5% 52.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -11.5% -8.2% -6.0% -2.7% 1.5% 5.8% 0.0% 0.0%   ROI %   -11.8% -8.7% -6.5% -2.9% 1.7% 6.1% 0.0% 0.0%   ROE %   -116.5% -67.0% -1.8% -47.7% -2.4% 42.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -87.1% -83.7% -86.0% -90.7% -83.8% -86.0% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -882.1% -1,072.8% -1,410.3% -3,381.8% 4,667.7% 1,464.0% 0.0% 0.0%   Gearing %   -111.2% -109.7% -108.4% -104.9% -107.6% -115.3% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.5% 2.5% 2.5% 2.5% 2.5% 2.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.9 1.9 2.0 1.6 1.5 13.6 0.0 0.0   Current Ratio   3.9 1.9 2.0 1.7 1.6 15.5 0.0 0.0   Cash and cash equivalent   1,393.6 3,177.2 2,472.4 1,776.2 3,847.2 1,882.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   2,025.5 1,874.3 1,642.4 871.3 1,557.3 3,131.6 -11,001.2 -11,001.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -1,156 -1,954 -1,523 -338 218 531 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -1,156 -1,954 -1,523 -338 231 531 0 0   EBIT / employee   -1,180 -2,004 -1,560 -349 208 516 0 0   Net earnings / employee   -1,190 -2,415 -72 -714 -42 577 0 0